ResearcherLudwig-Maximilians-Universität MünchenNo recent work listed

Elise Pretzsch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0678-3128; OpenAlex author ID A5049185040. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2021: 1 paper

Papers 1

Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matche… Co-author DOI 10.1186/s12893-021-01083-9 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Rainer Christoph Miksch · 1 shared paper, 2021 · strength 0.12
- Paper Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for panc… DOI 10.1186/s12893-021-01083-9 ↗
Bernhard Willibald Renz · 1 shared paper, 2021 · strength 0.12
- Paper Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for panc… DOI 10.1186/s12893-021-01083-9 ↗
Matthias Ilmer · 1 shared paper, 2021 · strength 0.12
- Paper Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for panc… DOI 10.1186/s12893-021-01083-9 ↗
Hanno Nieß · 1 shared paper, 2021 · strength 0.12
- Paper Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for panc… DOI 10.1186/s12893-021-01083-9 ↗
Jan Goesta D’Haese · 1 shared paper, 2021 · strength 0.12
- Paper Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for panc… DOI 10.1186/s12893-021-01083-9 ↗
Jens Werner · 1 shared paper, 2021 · strength 0.12
- Paper Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for panc… DOI 10.1186/s12893-021-01083-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.